AC
STIM icon

Aristides Capital’s Neuronetics STIM Stock Holding History

Aristides Capital’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-136,400
Closed -$188K – 271
2025
Q4 		$188K Buy
+136,400
New +$285K 0.03% 195
2022
Q1 		– Sell
-14,552
Closed -$65K – 283
2021
Q4 		$65K Buy
+14,552
New +$71.3K 0.03% 256
2020
Q1 		– Sell
-13,663
Closed -$61K – 232
2019
Q4 		$61K Buy
+13,663
New +$84.9K 0.05% 216

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Aristides Capital's STIM Position: Q1 2026 in Review

Aristides Capital sold out of Neuronetics (STIM) in Q1 2026, closing a stake of 136,400 shares — an estimated $188K sold.

Aristides Capital first reported a position in STIM in Q4 2019 and held it in 3 quarters. The position peaked at $188K in Q4 2025. 99 funds tracked by Wall St. Rank hold STIM as of Q1 2026.

  • Aristides Capital reported no remaining Neuronetics position as of Q1 2026 after selling out during the quarter.
  • Aristides Capital sold 136,400 Neuronetics shares in Q1 2026, an estimated $188K.
  • Aristides Capital first reported a position in Neuronetics in Q4 2019 and held it in 3 quarters.
  • Aristides Capital's Neuronetics position peaked at $188K in Q4 2025.
  • 99 funds tracked by Wall St. Rank held Neuronetics as of Q1 2026.

Based on Aristides Capital's 13F filing for Q1 2026, filed 14 May 2026.